Abnormal expression and processing of uromodulin in Fabry disease reflects tubular cell storage alteration and is reversible by enzyme replacement therapy
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- alfa-galaktosidasa terapeutické užití MeSH
- biologické markery metabolismus MeSH
- dospělí MeSH
- Fabryho nemoc farmakoterapie metabolismus patologie MeSH
- ledvinové kanálky metabolismus patologie MeSH
- lidé středního věku MeSH
- lidé MeSH
- molekulární sekvence - údaje MeSH
- mucin 1 metabolismus MeSH
- mukoproteiny metabolismus moč MeSH
- nemoci ledvin etiologie metabolismus patologie MeSH
- posttranslační úpravy proteinů * MeSH
- sekvence aminokyselin MeSH
- trihexosylceramidy metabolismus MeSH
- uromodulin MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- alfa-galaktosidasa MeSH
- biologické markery MeSH
- globotriaosylceramide MeSH Prohlížeč
- MUC1 protein, human MeSH Prohlížeč
- mucin 1 MeSH
- mukoproteiny MeSH
- trihexosylceramidy MeSH
- UMOD protein, human MeSH Prohlížeč
- uromodulin MeSH
Uromodulin (UMOD) malfunction has been found in a range of autosomal dominant tubulointerstitial nephropathies associated with hyperuricaemia, gouty arthritis, medullary cysts and renal failure-labelled as familial juvenile hyperuricaemic nephropathy, medullary cystic disease type 2 and glomerulocystic kidney disease. To gain knowledge of the spectrum of UMOD changes in various genetic diseases with renal involvement we examined urinary UMOD excretion and found significant quantitative and qualitative changes in 15 male patients at various clinical stages of Fabry disease. In untreated patients, the changes ranged from normal to a marked decrease, or even absence of urinary UMOD. This was accompanied frequently by the presence of aberrantly processed UMOD lacking the C-terminal part following the K432 residue. The abnormal patterns normalized in all patients on enzyme replacement therapy and in some patients on substrate reduction therapy. Immunohistochemical analysis of the affected kidney revealed abnormal UMOD localization in the thick ascending limb of Henle's loop and the distal convoluted tubule, with UMOD expression inversely proportional to the degree of storage. Our observations warrant evaluation of tubular functions in Fabry disease and suggest UMOD as a potential biochemical marker of therapeutic response of the kidney to therapy. Extended comparative studies of UMOD expression in kidney specimens obtained during individual types of therapies are therefore of great interest.
Zobrazit více v PubMed
Traffic. 2006 Nov;7(11):1567-79 PubMed
Lab Invest. 1971 Jul;25(1):92-5 PubMed
Am J Kidney Dis. 2003 Aug;42(2):E20-6 PubMed
Virchows Arch B Cell Pathol. 1969;2(3):239-54 PubMed
EMBO J. 2004 Apr 7;23(7):1657-68 PubMed
Hum Mol Genet. 2003 Dec 15;12(24):3369-84 PubMed
Am J Med. 1973 Sep;55(3):415-25 PubMed
Biochem Biophys Res Commun. 2001 Jan 12;280(1):110-4 PubMed
Nephrol Dial Transplant. 2003 Jan;18(1):7-9 PubMed
Histochem J. 1988 Mar;20(3):156-64 PubMed
Urol Res. 2004 May;32(2):79-83 PubMed
Kidney Int. 2002 May;61(5):1646-54 PubMed
Lab Invest. 1981 Mar;44(3):280-7 PubMed
Biochem Biophys Res Commun. 2001 Dec 21;289(5):1044-8 PubMed
Nephrol Dial Transplant. 2003 Jan;18(1):33-5 PubMed
J Am Soc Nephrol. 2002 Jun;13 Suppl 2:S134-8 PubMed
J Am Soc Nephrol. 2003 Nov;14(11):2883-93 PubMed
Ann Intern Med. 1965 Dec;63(6):1059-68 PubMed
Am J Pathol. 1981 May;103(2):247-62 PubMed
Pediatrie. 1978 Dec;33(8):757-65 PubMed
Adv Nephrol Necker Hosp. 1989;18:113-27 PubMed
Joint Bone Spine. 2004 Sep;71(5):381-3 PubMed
Biochem Biophys Res Commun. 1993 Jul 30;194(2):784-90 PubMed
Kidney Int. 1978 Mar;13(3):223-35 PubMed
J Urol. 1965 Jun;93:641-8 PubMed
Br Med J (Clin Res Ed). 1983 Dec 17;287(6408):1838-40 PubMed
J Mol Med (Berl). 2005 Aug;83(8):647-54 PubMed
Kidney Int. 1979 Sep;16(3):279-89 PubMed
J Biol Chem. 1990 Dec 5;265(34):20784-9 PubMed
Intern Med. 2000 Aug;39(8):601-2 PubMed
Arch Pathol Lab Med. 1985 Jan;109(1):85-8 PubMed
J Comput Assist Tomogr. 2004 Mar-Apr;28(2):158-68 PubMed
Nephrol Dial Transplant. 2004 Apr;19(4):1018 PubMed
J Anat. 1981 Jun;132(Pt 4):597-605 PubMed
Pathobiol Annu. 1981;11:229-57 PubMed
Am J Kidney Dis. 2004 Dec;44(6):987-99 PubMed
Infect Immun. 2002 May;70(5):2650-6 PubMed
Kidney Int. 1990 Jun;37(6):1395-401 PubMed
J Med Genet. 2002 Dec;39(12):882-92 PubMed
Pediatr Nephrol. 2006 Aug;21(8):1185-8 PubMed
Arch Pathol Lab Med. 1980 Jan;104(1):17-25 PubMed
J Am Soc Nephrol. 2007 Mar;18(3):698-706 PubMed
Kidney Int. 2005 Oct;68(4):1472-82 PubMed
Development. 2003 Oct;130(19):4751-9 PubMed
Kidney Int. 2006 Sep;70(6):1155-69 PubMed
Kidney Int. 2004 Sep;66(3):974-7 PubMed
Bull Mem Soc Med Hop Paris. 1966 Jan 14;117(1):49-57 PubMed